Capillary Biomedical Completes Initial Close of Series Seed Financing

Capillary Biomedical

Represented Capillary Biomedical in connection with the initial closing of its Series Seed financing, raising $2 million.

Capillary Biomedical is a medical device startup developing technologies for diabetes management. The company, based in Irvine, CA, spun out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Pennsylvania.

The Newport Beach-based deal team representing Capillary included Bruce FeuchterJeff Estes and Arash Lessantiz.